High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$349K
$349,632
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
GALT
M
GALECTIN THERAPEUTICS INC
Shlevin Harold H.
• Director
Equity Compensation
2025-12-17
$39,600x2
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Director
Equity Compensation
|
2025-12-17 | $39,600x2 | M | Form 4 |
|
GALT
S
GALECTIN THERAPEUTICS INC
Shlevin Harold H.
• Director
10b5-1 SellΔOwn -42.0%
2025-12-17
$172,424x2
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Director
10b5-1 SellΔOwn -42.0%
|
2025-12-17 | $172,424x2 | S | Form 4 |
|
GALT
M
GALECTIN THERAPEUTICS INC
Shlevin Harold H.
• Director
Equity Compensation
2025-12-15
$35,015x2
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Director
Equity Compensation
|
2025-12-15 | $35,015x2 | M | Form 4 |
|
GALT
S
GALECTIN THERAPEUTICS INC
Shlevin Harold H.
• Director
10b5-1 SellΔOwn -42.9%
2025-12-15
$53,027
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Director
10b5-1 SellΔOwn -42.9%
|
2025-12-15 | $53,027 | S | Form 4 |
|
GALT
M
GALECTIN THERAPEUTICS INC
Shlevin Harold H.
• Director
Equity Compensation
2025-12-12
$82,339x2
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Director
Equity Compensation
|
2025-12-12 | $82,339x2 | M | Form 4 |
|
GALT
S
GALECTIN THERAPEUTICS INC
Shlevin Harold H.
• Director
10b5-1 SellΔOwn -63.9%
2025-12-12
$124,181
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Director
10b5-1 SellΔOwn -63.9%
|
2025-12-12 | $124,181 | S | Form 4 |